Amfepentorex

Overview

Amfepentorex also known as CB-2201 is a stimulant drug derived from methamphetamine which was used as an appetite suppressant for the treatment of obesity, mainly in France in the 1970s. Dosage is 50–100 mg per day. Side effects include insomnia, hypertension and acute glaucoma.

Amfepentorex
INN: Amfepentorex
Clinical data
ATC code
  • none
Identifiers
  • (±)-N-methyl-1-(4-pentylphenyl)propan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC15H25N
Molar mass219.372 g·mol−1
3D model (JSmol)
  • N(C(Cc1ccc(cc1)CCCCC)C)C
  • InChI=1S/C15H25N/c1-4-5-6-7-14-8-10-15(11-9-14)12-13(2)16-3/h8-11,13,16H,4-7,12H2,1-3H3 checkY
  • Key:XWNBHORZFYYYIJ-UHFFFAOYSA-N checkY
 X markNcheckY (what is this?)  (verify)

Amfepentorex (INNTooltip International Nonproprietary Name) also known as CB-2201 is a stimulant drug derived from methamphetamine which was used as an appetite suppressant for the treatment of obesity, mainly in France in the 1970s.[1][2] Dosage is 50–100 mg per day. Side effects include insomnia, hypertension and acute glaucoma.

References

  1. ↑ Ganellin CR, Triggle DJ (1997). "A00258: Amfepentorex". Dictionary of pharmacological agents. London: Chapman & Hall. ISBN 978-0-412-46630-4.
  2. ↑ "Amfepentorex". NCATS Inxight Drugs. Archived from the original on 2025-04-20.


Related

No related data.

Recommendations